UK Switches to Gardasil for Protection Against Cervical Cancer

by Dr. Trupti Shirole on  November 25, 2011 at 3:26 PM Women Health News
RSS Email Print This Page Comment
The Department of Health, UK has decided to vaccinate teenage girls (aged 12-13 years) against sexual diseases with Gardasil instead of the currently used Cervarix jab. Gardasil is made by Sanofi Pasteur MSD. 80-million doses of this vaccine have been distributed worldwide.
 UK Switches to Gardasil for Protection Against Cervical Cancer
UK Switches to Gardasil for Protection Against Cervical Cancer

Cervarix manufactured by GlaxoSmithKline, protects against two strains of the human papilloma virus (HPV type 16 and 18) which cause cervical cancer. Cervarix will now be replaced by quadrivalent Gardasil in the national vaccination program. This vaccine protects against further two strains and prevents up to 90% of genital warts.

This change will come into effect from September next year.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Women and Cancer Cancer and Homeopathy Cervical Cancer Cancer Facts Cancer Tattoos A Body Art Uterine Cancer AIDS-HIV-Cancer Health Screening for Women Pap smear and Cervical Cancer Screening 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive